Skip to main content

Table 3 Characteristics of patients developing/ not developing AKI at entry into study

From: Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

  AKI event during follow-up No AKI event during follow-up
(n = 4944) (n = 20,204)
Age (Years) a 71.7 (64.7 – 78.3) 63.4 (54.2 – 72.1)
Male Sex (%) 2694 (54.5) 11,031 (54.6)
HbA1c % 7.2 (6.4- 8.3) 7.0 (7.4- 8.4)
(mmol/mol) a 55 (46 – 67) 53 (45 - 68)
Diabetes Duration (years) a 0 (0 – 3) 3.3 (0 – 9)
Number of diabetes drug classes (%)
0 2583 (52) 14,212 (70)
1 1617 (33) 4471 (22)
2 706 (14) 1438 (7)
3 27 (0.5) 76 (0.4)
4 1 6
5 0 1
ACE/ARB use (%) 1505 (30) 4667 (23)
NSAID use (%) 474 (10) 2079 (10)
  1. aMedian & IQR